Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Annovis Bio Inc ANVS

Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced... see more

Recent & Breaking News (NYSE:ANVS)

CLASS ACTION UPDATE for PLL, ZY and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 13, 2021

CLASS ACTION UPDATE for OTLY, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 12, 2021

CLASS ACTION UPDATE for ATVI, YALA and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 12, 2021

DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Annovis Bio, Inc. Securities Fraud Class Action Lawsuit

Newsfile September 10, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS

Newsfile September 10, 2021

ANVS Investor Alert: Shareholder Lawsuit Filed

Newsfile September 10, 2021

LAWSUITS FILED AGAINST AHCO, PHG and ANVS - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 10, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 10, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BZ, ZY and ANVS

Accesswire September 10, 2021

Annovis Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

PR Newswire September 10, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANVS, SESN and SAVA

Accesswire September 10, 2021

LAWSUITS FILED AGAINST BZ, SLQT and ANVS - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 9, 2021

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, Inc. (ANVS)

PR Newswire September 9, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BZ, ATVI and ANVS

Accesswire September 9, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OTLY, ZY and ANVS

Accesswire September 9, 2021

CLASS ACTION UPDATE for YMM, QFIN and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 9, 2021

ANVS Investor Alert: Class Action Lawsuit Filed

Newsfile September 9, 2021

INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 9, 2021

SHAREHOLDER ALERT: COIN OTLY ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 9, 2021

ANVS CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Annovis Bio, Inc.

PR Newswire September 8, 2021